Mike Kratky
Stock Analyst at Leerink Partners
(4.32)
# 1,330
Out of 4,596 analysts
267
Total ratings
45.8%
Success rate
12.9%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintained: Buy | $74 → $60 | $46.73 | +28.40% | 9 | Jul 30, 2026 | |
| EW Edwards Lifesciences | Upgraded: Buy | $87 → $101 | $86.07 | +17.35% | 32 | Jul 24, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $600 → $454 | $353.33 | +28.49% | 23 | Jul 17, 2026 | |
| MDT Medtronic | Maintained: Buy | n/a | $85.39 | - | 8 | Jul 10, 2026 | |
| PRCT PROCEPT BioRobotics | Downgraded: Hold | $65 → $29 | $18.62 | +55.75% | 19 | Jun 12, 2026 | |
| SYK Stryker | Initiated Coverage: Buy | $410 | $325.70 | +25.88% | 1 | Apr 13, 2026 | |
| ZBH Zimmer Biomet Holdings | Initiated Coverage: Hold | $101 | $93.93 | +7.53% | 1 | Apr 13, 2026 | |
| PEN Penumbra | Downgraded: Hold | $327 → $374 | $321.19 | +16.44% | 8 | Jan 15, 2026 | |
| ABT Abbott Laboratories | Reiterated: Hold | $136 | $105.70 | +28.67% | 4 | Oct 16, 2025 | |
| VCEL Vericel | Maintained: Buy | $50 → $48 | $45.96 | +4.44% | 18 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 → $84 | $83.45 | +0.66% | 21 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $333 → $355 | $165.35 | +114.70% | 15 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $29 | $19.50 | +48.72% | 17 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $96 | $50.21 | +91.20% | 28 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $52.62 | - | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $12.83 | +118.24% | 5 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $42.21 | -47.88% | 17 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $12.89 | +39.64% | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $256.35 | n/a | 1 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,148.84 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $46 | $1.04 | n/a | 11 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $31 | $103.40 | n/a | 10 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $18.92 | n/a | 1 | Aug 15, 2022 |
Boston Scientific
Jul 30, 2026
Maintained: Buy
Price Target: $74 → $60
Current: $46.73
Upside: +28.40%
Edwards Lifesciences
Jul 24, 2026
Upgraded: Buy
Price Target: $87 → $101
Current: $86.07
Upside: +17.35%
Intuitive Surgical
Jul 17, 2026
Reiterated: Buy
Price Target: $600 → $454
Current: $353.33
Upside: +28.49%
Medtronic
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $85.39
Upside: -
PROCEPT BioRobotics
Jun 12, 2026
Downgraded: Hold
Price Target: $65 → $29
Current: $18.62
Upside: +55.75%
Stryker
Apr 13, 2026
Initiated Coverage: Buy
Price Target: $410
Current: $325.70
Upside: +25.88%
Zimmer Biomet Holdings
Apr 13, 2026
Initiated Coverage: Hold
Price Target: $101
Current: $93.93
Upside: +7.53%
Penumbra
Jan 15, 2026
Downgraded: Hold
Price Target: $327 → $374
Current: $321.19
Upside: +16.44%
Abbott Laboratories
Oct 16, 2025
Reiterated: Hold
Price Target: $136
Current: $105.70
Upside: +28.67%
Vericel
Oct 14, 2025
Maintained: Buy
Price Target: $50 → $48
Current: $45.96
Upside: +4.44%
Oct 14, 2025
Maintained: Buy
Price Target: $101 → $84
Current: $83.45
Upside: +0.66%
Oct 14, 2025
Maintained: Buy
Price Target: $333 → $355
Current: $165.35
Upside: +114.70%
Oct 14, 2025
Maintained: Buy
Price Target: $32 → $29
Current: $19.50
Upside: +48.72%
Oct 14, 2025
Maintained: Hold
Price Target: $96
Current: $50.21
Upside: +91.20%
Oct 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $52.62
Upside: -
Sep 12, 2025
Reiterated: Buy
Price Target: $28
Current: $12.83
Upside: +118.24%
Aug 25, 2025
Maintained: Buy
Price Target: $22
Current: $42.21
Upside: -47.88%
Aug 13, 2025
Reiterated: Buy
Price Target: $17 → $18
Current: $12.89
Upside: +39.64%
Apr 5, 2024
Maintained: Buy
Price Target: n/a
Current: $256.35
Upside: n/a
Oct 16, 2023
Maintained: Buy
Price Target: n/a
Current: $1,148.84
Upside: n/a
Sep 26, 2023
Maintained: Buy
Price Target: $45 → $46
Current: $1.04
Upside: n/a
May 4, 2023
Reiterated: Hold
Price Target: $31
Current: $103.40
Upside: n/a
Aug 15, 2022
Maintained: Buy
Price Target: $40
Current: $18.92
Upside: n/a